Omkar Pharmachem Reports Q2 Results for Period Ended 30th Sep'26
Omkar Pharmachem Ltd · Financial Result · 14 Nov 2026, 11:01 pm
Omkar Pharmachem Reports Q2 Results for Period Ended 30th Sep'26 Omkar Pharmachem reported net total income of ₹9.00 lakh for the quarter ended 30th Sep'26, flat QoQ and down 35.4% YoY from ₹13.94 lakh. Total expenses stood at ₹8.61 lakh compared to ₹10.00 lakh in the previous quarter and ₹7.14 lakh in the year-ago period. Net profit for Q2 reached ₹0.39 lakh, recovering from a net loss of ₹1.00 lakh in Q1, but declining 92.3% YoY from ₹5.07 lakh. For H1 ended 30th Sep'26, the company recorded a net loss of ₹0.62 lakh.
Original exchange filing (PDF)
More announcements from Omkar Pharmachem Ltd
- Dear Sir/Ma''am, Please find Qutcome of the Board Meeting held on 14 November, 2026 for approval of Unaudited Financial Results of the Company along with Statement of Assets and Liabilities, .... · 14 Nov 2026
- Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Omkar Pharmachem Ltd has informed .... · 14 Nov 2026
- Dear Sir/Ma''am, Please find Voting Results of 31st AGM along with Consolidated Scrutinizer Report. · 01 Oct 2026
- Dear Sir/Ma''am, Please find Proceeding of 31st AGM & Reporting Under Reg. 30 of SEBI(LODR) Regulation, 2015 · 30 Sept 2026
- Dear Sir, Please find intimation under regulation 42 of SEBI Listing Obligations and Disclosure Requirements) Regulations, 2015 · 02 Sept 2026
- 31st Annual Report of the company along with Notice of AGM for the Financial year 2025-26 · 02 Sept 2026
- Pursuant to Regulation 30 of SEBI( Listing Obligations and Disclosures requirements) Regulations, 2015, Please find attached herewith the Notice convening 31st Annual General Meeting of the Company · 02 Sept 2026
- Outcome of the Board Meeting held on 31st August, 2026 · 31 Aug 2026
